Document is current
Any future updates will be listed below
-
Authors
Meier, Philip
Glasmacher, Sandra
Salmen, Anke
Chan, Andrew
Gertsch, Jürg https://orcid.org/0000-0003-0978-1555
-
Funding
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (189220)
- License Information
-
More Information
Article History
Received: 23 July 2024
Accepted: 14 September 2024
First Online: 10 October 2024
Declarations
:
: The study was performed in accordance with the declaration of Helsinki and was approved by the cantonal ethics committee of Bern (Project-ID: 2020–02164).
: All patients provided written informed consent for the collection, storage and usage of biological material and medical documentation for research purposes.
: AS received speaker honoraria for activities with Bristol Myers Squibb, CSL Behring, Merck, Neuraxpharm, and Novartis, and research support by the Baasch Medicus Foundation, the Medical Faculty of the University of Bern, the Swiss MS Society and the regional association of North Rhine-Westphalia of the German MS Society (DMSG Landesverband NRW), all not related to this manuscript. All other authors have no competing interests to declare that are relevant to the content of this article.
